The CB1 cannabinoid receptor agonist reduces L-DOPA-induced motor fluctuation and ERK1/2 phosphorylation in 6-OHDA-lesioned rats

References

• Sherer TB Betarbet R Greenamyre JT Pathogenesis of Parkinson’s disease Curr Opin Investig Drugs 2001 2 5 657 662
   PubMedGoogle Scholar
• Simuni T Sethi K Nonmotor manifestations of Parkinson’s disease Ann Neurol 2008 64 Suppl 2 S65 S80 19127582
   PubMed Web of Science ®Google Scholar
• Eskow KL Dupre KB Barnum CJ Dickinson SO Park JY Bishop C The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats Synapse 2009 63 7 610 620 19309758
   PubMed Web of Science ®Google Scholar
• Carta M Carlsson T Kirik D Björklund A Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats Brain 2007 130 Pt 7 1819 1833 17452372
   PubMed Web of Science ®Google Scholar
• Jaunarajs KL Dupre KB Steiniger A Serotonin 1B receptor stimulation reduces D1 receptor agonist-induced dyskinesia Neuroreport 2009 20 14 1265 1269 19633584
   PubMed Web of Science ®Google Scholar
• Santini E Valjent E Fisone G Parkinson’s disease: levodopa-induced dyskinesia and signal transduction FEBS J 2008 275 7 1392 1399 18279379
   PubMed Web of Science ®Google Scholar
• Fox SH Chuang R Brotchie JM Parkinson’s disease – opportunities for novel therapeutics to reduce the problems of levodopa therapy Prog Brain Res 2008 172 479 494 18772047
   PubMed Web of Science ®Google Scholar
• Pavón N Martín AB Mendialdua A Moratalla R ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice Biol Psychiatry 2006 59 1 64 74 16139809
   PubMed Web of Science ®Google Scholar
• Santini E Valjent E Usiello A Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia J Neurosci 2007 27 26 6995 7005 17596448
   PubMed Web of Science ®Google Scholar
• Westin JE Vercammen L Strome EM Konradi C Cenci MA Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors Biol Psychiatry 2007 62 7 800 810 17662258
   PubMed Web of Science ®Google Scholar
• Fox SH Henry B Hill M Crossman A Brotchie J Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson’s disease Mov Disord 2002 17 6 1180 1187 12465055
   PubMed Web of Science ®Google Scholar
• Morgese MG Cassano T Cuomo V Giuffrida A Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson’s disease: role of CB(1) and TRPV1 receptors Exp Neurol 2007 208 1 110 119 17900568
   PubMed Web of Science ®Google Scholar
• Segovia G Mora F Crossman AR Brotchie JM Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high-dose levodopa in the reserpine-treated rat model of Parkinson’s disease Mov Disord 2003 18 2 138 149 12539206
   PubMed Web of Science ®Google Scholar
• Snow BJ Macdonald L Mcauley D Wallis W The effect of amantadine on levodopa-induced dyskinesias in Parkinson’s disease: a double-blind, placebo-controlled study Clin Neuropharmacol 2000 23 2 82 85 10803797
   PubMed Web of Science ®Google Scholar
• Andersson M Usiello A Borgkvist A Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons J Neurosci 2005 25 37 8432 8438 16162925
   PubMed Web of Science ®Google Scholar
• Paxinos G Watson C The Rat Brain in Stereotaxic Coordinates San Diego Academic Press 2007
   Google Scholar
• Papa SM Engber TM Kask AM Chase TN Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration Brain Res 1994 662 1–2 69 74 7859092
   PubMed Web of Science ®Google Scholar
• Ferrer B Asbrock N Kathuria S Piomelli D Giuffrida A Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias Eur J Neurosci 2003 18 6 1607 1614 14511339
   PubMed Web of Science ®Google Scholar
• Engber TM Papa SM Boldry RC Chase TN NMDA receptor blockade reverses motor response alterations induced by levodopa Neuroreport 1994 5 18 2586 2588 7696610
   PubMed Web of Science ®Google Scholar
• Marin C Jiménez A Bonastre M LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor fluctuations in Parkinsonian rats Synapse 2001 42 1 40 47 11668589
   PubMed Web of Science ®Google Scholar
• Marin C Aguilar E Bonastre M Tolosa E Obeso JA 2005. Early administration of entacapone prevents levodopa-induced motor fluctuations in hemiparkinsonian rats Exp Neurol 2005 192 1 184 193 15698633
   PubMed Web of Science ®Google Scholar
• Jenner P The MPTP-treated primate as a model of motor complications in PD: primate model of motor complications Neurology 2003 61 6 Suppl 3 S4 S11 14504374
   PubMed Web of Science ®Google Scholar
• García-Arencibia M García C Fernández-Ruiz J Cannabinoids and Parkinson’s disease CNS Neurol Disord Drug Targets 2009 8 6 432 439 19839934
   PubMed Web of Science ®Google Scholar
• Corbillé AG Valjent E Marsicano G Role of cannabinoid type 1 receptors in locomotor activity and striatal signaling in response to psychostimulants J Neurosci 2007 27 26 6937 6947 17596442
   PubMed Web of Science ®Google Scholar
• Lerner TN Horne EA Stella N Kreitzer AC Endocannabinoid signaling mediates psychomotor activation by adenosine A2A antagonists J Neurosci 2010 30 6 2160 2164 20147543
   PubMed Web of Science ®Google Scholar
• Pérez-Rial S García-Gutiérrez MS Molina JA Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors Neurobiol Aging 2011 32 4 631 645 19419794
   PubMed Web of Science ®Google Scholar
• Morissette M Dridi M Calon F Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors Synapse 2006 60 3 239 250 16739115
   PubMed Web of Science ®Google Scholar
• Johnston TH van der Meij A Brotchie JM Fox SH Effect of histamine H2 receptor antagonism on levodopa-induced dyskinesia in the MPTP-macaque model of Parkinson’s disease Mov Disord 2010 25 10 1379 1390 20310030
   PubMed Web of Science ®Google Scholar
• Ouattara B Hoyer D Grégoire L Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesias Neuroscience 2010 167 4 1160 1167 20303391
   PubMed Web of Science ®Google Scholar
• Cao X Liang L Hadcock JR Blockade of cannabinoid type 1 receptors augments the antiparkinsonian action of levodopa without affecting dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys J Pharmacol Exp Ther 2007 323 1 318 326 17630359
   PubMed Web of Science ®Google Scholar
• Greengard P The neurobiology of slow synaptic transmission Science 2001 294 5544 1024 1030 11691979
   PubMed Web of Science ®Google Scholar
• da Cruz e Silva EF Fox CA Ouimet CC Gustafson E Watson SJ Greengard P Differential expression of protein phosphatase 1 isoforms in mammalian brain J Neurosci 1995 15 5 Pt 1 3375 3389 7751917
   PubMed Web of Science ®Google Scholar
• Hemmings HCJr Greengard P Tung HY Cohen P DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1 Nature 1984 310 5977 503 505 6087160
   PubMed Web of Science ®Google Scholar
• Bibb JA Snyder GL Nishi A Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons Nature 1999 402 6762 669 671 10604473
   PubMed Web of Science ®Google Scholar
• Albin RL Young AB Penney JB The functional anatomy of basal ganglia disorders Trends Neurosci 1989 12 10 366 375 2479133
   PubMed Web of Science ®Google Scholar
• Bateup HS Svenningsson P Kuroiwa M Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs Nat Neurosci 2008 11 8 932 939 18622401
   PubMed Web of Science ®Google Scholar
• Xing J Ginty DD Greenberg ME Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase Science 1996 273 5277 959 963 8688081
   PubMed Web of Science ®Google Scholar